Are exon 19 deletions and L858R EGFR mutations in non-small-cell lung cancer clinically different?

被引：9

作者：

Costa, D. B. ^{[1
]}

Kobayashi, S. ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA

来源：

BRITISH JOURNAL OF CANCER | 2007年 / 96卷 / 02期

关键词：

D O I：

10.1038/sj.bjc.6603564

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：399 / 399

页数：1

共 5 条

[1]

[Anonymous], J CLIN ONCOL 1, DOI DOI 10.1200/jco.2006.24.18_suppl.7020

[2] A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations [J].

Asahina, H. ;

Yamazaki, K. ;

Kinoshita, I. ;

Sukoh, N. ;

Harada, M. ;

Yokouchi, H. ;

Ishida, T. ;

Ogura, S. ;

Kojima, T. ;

Okamoto, Y. ;

Fujita, Y. ;

Dosaka-Akita, H. ;

Isobe, H. ;

Nishimura, M. .

BRITISH JOURNAL OF CANCER, 2006, 95 (08) :998-1004

[3] Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations [J].

Inoue, Akira ;

Suzuki, Takuji ;

Fukuhara, Tatsuro ;

Maemondo, Makoto ;

Kimura, Yuichiro ;

Morikawa, Naoto ;

Watanabe, Hiroshi ;

Saijo, Yasuo ;

Nukiwa, Toshihiro .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) :3340-3346

[4] Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib [J].

Jackman, David M. ;

Yeap, Beow Y. ;

Sequist, Lecia V. ;

Lindeman, Neal ;

Holmes, Alison J. ;

Joshi, Victoria A. ;

Bell, Daphne W. ;

Huberman, Mark S. ;

Halmos, Balazs ;

Rabin, Michael S. ;

Haber, Daniel A. ;

Lynch, Thomas J. ;

Meyerson, Matthew ;

Johnson, Bruce E. ;

Jaenne, Pasi A. .

CLINICAL CANCER RESEARCH, 2006, 12 (13) :3908-3914

[5] Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib [J].

Riely, GJ ;

Pao, W ;

Pham, DK ;

Li, AR ;

Rizvi, N ;

Venkatraman, ES ;

Zakowski, MF ;

Kris, MG ;

Ladanyi, M ;

Miller, VA .

CLINICAL CANCER RESEARCH, 2006, 12 (03) :839-844

← 1 →